🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07729735
Enrolling by invitation Not applicable

Physiotherapy After Breast Reduction Surgery

NCT07729735 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-23
Last updated
2026-07-27

Condition(s) studied

BreastPostureMammaplastySleep Quality

Investigational drug(s) / intervention(s)

Physiotherapy

Physiotherapy: The participants will attend a physiotherapy programme. The programme includes some exercises.

Study summary

Background and Purpose:

Breast reduction surgery is a major procedure that can lead to post-operative pain, postural deviations, and a temporary decline in quality of life.This clinical study aims to investigate the efficacy of early-phase physical therapy on pain management, postural alignment, and overall quality of life in female patients following breast reduction surgery.

Study Design and Participants:

This is a controlled clinical trial involving 40 female participants aged 18 to 50 who have undergone their first breast reduction surgery. Participants are divided into two groups: an intervention group (n=20) and a control group (n=20). The study follows a pre-test and post-test design to evaluate outcomes before and after a three-week intervention period.

Intervention Protocol:

The intervention group receives a comprehensive physical therapy program starting one week post-operation. The program is conducted three days a week for three weeks, with sessions lasting 40 to 60 minutes The protocol includes:

Postural and cervical exercises Scapular stabilization and manual therapy Scar massage and Transcutaneous Electrical Nerve Stimulation (TENS) as needed A structured home exercise program.

Outcome Measures:

Primary and secondary outcomes are assessed through various clinical tools:

Pain:Visual Analog Scale (VAS) Posture: New York Posture Test, measurements of scapular protraction and cervical anterior tilt Mobility:Shoulder and cervical Range of Motion (ROM) Quality of Life and Health: SF-12, BREAST-Q, and Pittsburgh Sleep Quality Index (PSQI)

Expected Results:

The study anticipates that the early-phase physical therapy group will demonstrate a significant reduction in pain, improved postural alignment, and a higher quality of life compared to the control group.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Being between 18 and 50 years of age * Having undergone aesthetic breast reduction surgery * Having a complication-free postoperative period * Agreeing to participate in the study voluntarily and having signed the informed consent form Exclusion Criteria: 1. Oncological History: Those who have been diagnosed with breast cancer in the pre-operative or per-operative period, or those with a history of radiotherapy/chemotherapy to the breast area, 2. Lymphovenous Disorders: Those with lymphedema in the upper extremity or vascular insufficiency that may severely affect lymphatic drainage, 3. Musculoskeletal and Nervous System Pathologies: Those with orthopedic diseases such as severe scoliosis, ankylosing spondylitis, or neurological diseases such as brachial plexus lesions that may affect posture analysis and shoulder mobility, 4. Systemic Diseases: Those with uncontrolled Diabetes Mellitus, which directly negatively affects wound healing, or those with active autoimmune connective tissue diseases, 5. Exercise Contraindications: Patients with cardiopulmonary failure or severe cognitive impairment that would prevent participation in the physiotherapy protocol.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Rumeli university Istanbul Turkey (Türkiye)

More Istanbul Rumeli University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07729735 on ClinicalTrials.gov ↗ ← All trials in Turkey